Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIKI NASDAQ:DKDCA NASDAQ:LUCD NASDAQ:LUNA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIKIAIkido Pharma$6.96+4.7%$5.65$3.31▼$11.48$38.18M0.9379,326 shs215,378 shsDKDCAData Knights Acquisition$0.86+3.1%$0.64$5.00▼$13.51$4.44M0.1839,705 shs269,134 shsLUCDLucid Diagnostics$1.03-3.7%$1.11$0.73▼$1.80$111.73M1.241.06 million shs1.30 million shsLUNALuna Innovations$0.95+5.6%$0.91$0.22▼$2.47$32.26M2141,151 shs3,754 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIKIAIkido Pharma-4.32%+12.33%+24.77%+26.43%+240.15%DKDCAData Knights Acquisition-1.23%-1.07%+82.51%+131.84%+9.05%LUCDLucid Diagnostics+4.90%-22.46%+7.27%-17.05%+28.73%LUNALuna Innovations+9.76%-6.25%-10.00%+20.00%-58.14%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIKIAIkido Pharma$6.96+4.7%$5.65$3.31▼$11.48$38.18M0.9379,326 shs215,378 shsDKDCAData Knights Acquisition$0.86+3.1%$0.64$5.00▼$13.51$4.44M0.1839,705 shs269,134 shsLUCDLucid Diagnostics$1.03-3.7%$1.11$0.73▼$1.80$111.73M1.241.06 million shs1.30 million shsLUNALuna Innovations$0.95+5.6%$0.91$0.22▼$2.47$32.26M2141,151 shs3,754 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIKIAIkido Pharma-4.32%+12.33%+24.77%+26.43%+240.15%DKDCAData Knights Acquisition-1.23%-1.07%+82.51%+131.84%+9.05%LUCDLucid Diagnostics+4.90%-22.46%+7.27%-17.05%+28.73%LUNALuna Innovations+9.76%-6.25%-10.00%+20.00%-58.14%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIKIAIkido Pharma 0.00N/AN/AN/ADKDCAData Knights Acquisition 0.00N/AN/AN/ALUCDLucid Diagnostics 3.00Buy$3.65254.37% UpsideLUNALuna Innovations 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest AIKI, LUNA, DKDCA, and LUCD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/5/2025LUCDLucid DiagnosticsBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$2.00 ➝ $2.508/13/2025LUCDLucid DiagnosticsNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$3.007/16/2025LUCDLucid DiagnosticsNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$3.00(Data available from 9/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIKIAIkido PharmaN/AN/AN/AN/A$19.27 per shareN/ADKDCAData Knights AcquisitionN/AN/A$0.01 per share111.42($1.82) per shareN/ALUCDLucid Diagnostics$4.35M25.69N/AN/A($0.78) per share-1.32LUNALuna Innovations$116.61M0.28$0.31 per share3.03N/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIKIAIkido Pharma-$7.17M-$3.88N/AN/AN/AN/A-18.21%-16.94%N/ADKDCAData Knights Acquisition$340K-$0.19N/A∞N/AN/AN/A-5.55%N/ALUCDLucid Diagnostics-$45.53M-$1.19N/AN/AN/A-1,476.35%N/A-120.43%11/12/2025 (Estimated)LUNALuna Innovations$9.28MN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIKIAIkido PharmaN/AN/AN/AN/AN/ADKDCAData Knights AcquisitionN/AN/AN/AN/AN/ALUCDLucid DiagnosticsN/AN/AN/AN/AN/ALUNALuna InnovationsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIKIAIkido PharmaN/A29.5429.54DKDCAData Knights AcquisitionN/AN/AN/ALUCDLucid DiagnosticsN/A1.151.13LUNALuna InnovationsN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIKIAIkido Pharma10.88%DKDCAData Knights Acquisition35.35%LUCDLucid Diagnostics74.01%LUNALuna Innovations87.46%Insider OwnershipCompanyInsider OwnershipAIKIAIkido Pharma8.60%DKDCAData Knights Acquisition45.72%LUCDLucid Diagnostics6.80%LUNALuna Innovations7.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIKIAIkido Pharma45.49 million5.01 millionNot OptionableDKDCAData Knights Acquisition25.17 million2.81 millionNot OptionableLUCDLucid Diagnostics70108.48 million101.10 millionNo DataLUNALuna Innovations39033.96 million31.38 millionOptionableAIKI, LUNA, DKDCA, and LUCD HeadlinesRecent News About These CompaniesVideo captures personality of rescue dog Luna - the RSPCA’s longest staying residentJuly 21, 2025 | msn.comNotable Latino Leaders: Jose LunaJuly 21, 2025 | biztimes.comBLA County Sheriff Luna Defends Compliance with Federal WarrantsJuly 20, 2025 | davisvanguard.orgDFlorida Rep. Luna Demands DOJ Probe Into Fed Chair Powell Over “Crazy” $2.5 RenovationJuly 19, 2025 | msn.comTraining facility blast caused ‘largest loss of life' for LASD, Sheriff Luna saysJuly 19, 2025 | msn.comExplosion is LASD’s deadliest day in nearly 170 years, Luna saysJuly 19, 2025 | msn.comKGB files on JFK to be released this fall: Rep. Anna Paulina LunaJuly 18, 2025 | msn.comKGB files on JFK assassination to be released in months: LunaJuly 18, 2025 | msn.comRep. Luna's Update on JFK Files: Lone Gunman Theory Destroyed by Witness at Hospital - Rogue CIA Factions Also at WorkJuly 18, 2025 | msn.comLASD transferred at least 20 inmates over to ICE. Sheriff Luna explains whyJuly 18, 2025 | msn.comIs Luna Really Dead on 'The Bold and the Beautiful'?July 18, 2025 | aol.comALA County cannot hand over immigrant inmates' data despite DOJ threat, Luna saysJuly 18, 2025 | msn.comDOJ wants data on non-citizen inmates in California, Luna calls it 'impossible'July 18, 2025 | yahoo.comDiego Luna To Star Opposite Taylor Kitsch In Kidnapping Thriller ‘Eleven Days’July 16, 2025 | msn.comThe Bold And The Beautiful Spoilers: Is Luna Hiding An Identical Twin? Discover the New ‘Ronna’ Character’s Major Twist!July 16, 2025 | celebratingthesoaps.comCUniversal Audio's Luna DAW updated with AI tools, including voice control and instrument detectionJuly 15, 2025 | msn.comThe Bold And The Beautiful Spoilers: Luna Might Not Be Dead After AllJuly 13, 2025 | celebratingthesoaps.comCThe Bold And The Beautiful Spoilers: Finn’s Heartbreak Over Luna’s Death And The Blame Game With SteffyJuly 13, 2025 | celebratingthesoaps.comCThe Bold and the Beautiful What-to-Watch Moments, July 14: Luna's death brings grief and mourningJuly 13, 2025 | soapcentral.comSThe Bold and the Beautiful Rewrites Luna’s Backstory– When Did Poppy Become The Villain?July 13, 2025 | celebratingthesoaps.comCNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAIKI, LUNA, DKDCA, and LUCD Company DescriptionsAIkido Pharma NASDAQ:AIKI$6.96 +0.31 (+4.66%) As of 09/11/2025AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.Data Knights Acquisition NASDAQ:DKDCA$0.86 +0.03 (+3.11%) As of 09/10/2025Data Knights Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the data centers and internet technology sectors. Data Knights Acquisition Corp. was incorporated in 2021 and is based in Frome, the United Kingdom.Lucid Diagnostics NASDAQ:LUCD$1.03 -0.04 (-3.74%) Closing price 04:00 PM EasternExtended Trading$1.06 +0.03 (+2.91%) As of 05:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.Luna Innovations NASDAQ:LUNA$0.95 +0.05 (+5.56%) As of 03:30 PM EasternLuna Innovations Incorporated provides fiber optic test, measurement, and control products worldwide. The company offers test and measurement equipment for fiber optic components and sub-assemblies; polarization control products, including components, modules, and instruments to measure, manage, and control polarization and group delay in fiber optic networks; tunable lasers; and single frequency lasers. It also provides ODiSI sensing solution, which provides distributed strain and temperature measurements; distributed temperature sensing system; hyperion sensing products; Terahertz Sensing Systems that provide precise single and multi-layer thickness, density, basis weight, and caliper thickness measurements; and distributed acoustic sensing products. The company primarily markets its fiber optic test, measurement, and control products to telecommunications companies, defense agencies, government system integrators, researchers, original equipment manufacturers, distributors, testing labs, and strategic partners directly, as well as through manufacturer representative organizations, partner and distribution channels, technical sales engineers, value added resellers, and independent sales representatives. Luna Innovations Incorporated was incorporated in 1990 and is headquartered in Roanoke, Virginia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Not Just NVDA: 3 Semiconductor Stocks Struggling This Quarter Broadcom Gets Big Upgrades: How High Analysts See Shares Going Why Micron Stock Could Outperform NVIDIA in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
